Literature DB >> 29671521

Acute Migraine Headache: Treatment Strategies.

Laura Mayans1, Anne Walling1.   

Abstract

Migraine is a primary headache disorder characterized by recurrent attacks. Acetaminophen, nonsteroidal anti-inflammatory drugs, triptans, antiemetics, ergot alkaloids, and combination analgesics have evidence supporting their effectiveness in the treatment of migraine. Acetaminophen and nonsteroidal anti-inflammatory drugs are first-line treatments for mild to moderate migraines, whereas triptans are first-line treatments for moderate to severe migraines. Although triptans are effective, they may be expensive. Other medications such as dihydroergotamine and antiemetics are recommended for use as second- or third-line therapy for select patients or for those with refractory migraine. The pharmacologic properties, potential adverse effects, cost, and routes of administration vary widely, allowing therapy to be individualized based on the pattern and severity of attacks. Several treatment principles, including taking medication early in an attack and using a stratified treatment approach, can help ensure that migraine treatment is cost-effective.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29671521

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

Review 1.  Understandings of acupuncture application and mechanisms.

Authors:  Jaung-Geng Lin; Peddanna Kotha; Yi-Hung Chen
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  A Comprehensive Review of Over-the-counter Treatment for Chronic Migraine Headaches.

Authors:  Jacquelin Peck; Ivan Urits; Justin Zeien; Shelby Hoebee; Mohammad Mousa; Hamed Alattar; Alan D Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

3.  The Frequency and Perceived Effectiveness of Pain Self-Management Strategies Used by Individuals With Migraine.

Authors:  Hao-Yuan Chang; Chih-Chao Yang; Mark P Jensen; Yeur-Hur Lai
Journal:  J Nurs Res       Date:  2021-04-09       Impact factor: 1.682

4.  Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study.

Authors:  Domenico Chirchiglia; Erika Cione; Maria C Caroleo; Minyan Wang; Giulio Di Mizio; Noemi Faedda; Teodosio Giacolini; Serena Siviglia; Vincenzo Guidetti; Luca Gallelli
Journal:  Front Neurol       Date:  2018-08-17       Impact factor: 4.003

Review 5.  A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu Wang; Yajun Shi; Xiaofei Zhang; Junbo Zou; Yulin Liang; Jia Tai; Mei Wang; Chunli Cui; Dongyan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-31       Impact factor: 2.629

6.  Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials.

Authors:  Pei-Wen Chi; Kun-Yi Hsieh; Kuan-Yu Chen; Chin-Wang Hsu; Chyi-Huey Bai; Chiehfeng Chen; Yuan-Pin Hsu
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

7.  Migraine Headaches after Major Surgery with General or Neuraxial Anesthesia: A Nationwide Propensity-Score Matched Study.

Authors:  Chung-Yi Liao; Chun-Cheng Li; Hsin-Yi Liu; Jui-Tai Chen; Yih-Giun Cherng; Tzeng-Ji Chen; Ying-Xiu Dai; Hsiang-Ling Wu; Wan-Chi Liu; Ying-Hsuan Tai
Journal:  Int J Environ Res Public Health       Date:  2021-12-30       Impact factor: 3.390

Review 8.  Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review.

Authors:  Neysan Chah; Mike Jones; Steve Milord; Kamal Al-Eryani; Reyes Enciso
Journal:  J Dent Anesth Pain Med       Date:  2021-10-01

9.  Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant.

Authors:  Karissa M Johnston; Gilbert L'Italien; Evan Popoff; Lauren Powell; Robert Croop; Alexandra Thiry; Linda Harris; Vladimir Coric; Richard B Lipton
Journal:  Adv Ther       Date:  2021-08-29       Impact factor: 3.845

Review 10.  Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research.

Authors:  Eleonóra Spekker; Masaru Tanaka; Ágnes Szabó; László Vécsei
Journal:  Biomedicines       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.